Gaucher Association Logo

Promoting awareness, pioneering research and providing support and information for those affected by Gaucher disease.


Telephone: 01453 549231

In the News

  • October update

    26 October 2017

    Dr Patrick Deegan and Clinical Nurse Specialist Elizabeth Morris from Addbenbrooke's Hospital, Cambridge have very kindly answered some questions you may have about Cerdelga to help you fully understand before making any decisions

    read more »

  • Jeans for Genes Day

    8 August 2017

    Jeans for Genes is the annual fundraising campaign for Genetic Disorders UK, the national charity that supports individuals and families affected by a genetic disorder. 
    It is estimated that one in 25 children is affected by a …

    read more »

  • Drugs Industry to sue over price cap on NHS medicines

    11 July 2017

    The pharmaceutical industry is planning to sue the drugs watchdog over the price cap on medicines.
    The Association of the British Pharmaceutical Industry (ABPI) said it has applied for a judicial review after a Government shake-up …

    read more »

  • Final Place for The Great North Run

    21 June 2017

    FINAL PLACE....... We would love to fill the final place that we have available for The Great North Run. This iconic event is taking place on 10th September 2017.This could be your chance to take part in the same race as some of the worlds …

    read more »

  • NICE says ‘YES’ to NHS paying for Cerdelga for adult patients with Type 1 Gaucher Disease

    31 May 2017

    Today, the National Institute for Health and Care Excellence (NICE) announced that Cerdelga is recommended within its marketing authorisation for treating type 1 Gaucher disease, that is, for long-term treatment in adults who are cytochrome …

    read more »

  • PRESS RELEASE - NICE and NHS England

    28 March 2017

    In late October 2016 NHS England and NICE launched a 12-week consultation on changes to the arrangements for evaluating and funding drugs and other health technologies appraised through NICE’s Highly Specialised Technologies (HST) …

    read more »

  • Clinical Trial for Gaucher Disease Type 3

    21 February 2017

    Sanofi Genzyme is investigating an orally administered substrate reduction therapy in Gaucher disease type 3 as part of the 2-part LEAP clinical research study.

    The first part of the LEAP study will measure and compare certain factors in …

    read more »

  • Gauchers Association charity cycle ride 2017

    17 February 2017

    Back by popular demand with a brand new revised 60 (or 40) mile cicular route.

    Sunday 21st May 2017 - Online registration NOW OPEN! 

    Register early to guarantee your place  Why not invite your friends to take part too?

    read more »

  • Clinical Trial ALERT!!!

    3 January 2017

    Genzyme, a Sanofi Company have launched a phase 2 clinical trial in adults (18 years and older) with Type 3 Gaucher disease. This 52-week two-part study is currently open and recruiting patients in the UK and the US.

    To be eligible for this …

    read more »

  • Season's Greetings 2016

    16 December 2016

    The Gauchers Association would like to take this opportunity to wish all our members, families, friends and all our collaborative partners Seasonal Greetings and best wishes for the New Year.

    We should like to inform you that the office will …

    read more »